NUMINUS WELLNESS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.045 CAD | 0.00% |
|
-10.00% | -59.09% |
| 20/06 | Numinus Wellness Signs Letter of Intent to Buy MedBright AI Investments | MT |
| 20/06 | Numinus Wellness Brief: MedBright AI Announcing Strategic Acquisition by Numinus Wellness | MT |
Valuation
| Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 22.48 | 172.5 | 92.25 | 51.96 | 14.42 | - | - |
| Enterprise Value (EV) 1 | 22.48 | 172.5 | 92.25 | 51.96 | 14.42 | 14.42 | 14.42 |
| P/E ratio | -1.57 x | - | - | -1.77 x | -0.9 x | -4.5 x | - |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 25.5 x | 114 x | 14.2 x | 2.24 x | 0.66 x | 0.52 x | 0.37 x |
| EV / Revenue | 25.5 x | 114 x | 14.2 x | 2.24 x | 0.66 x | 0.52 x | 0.37 x |
| EV / EBITDA | - | -1,12,06,812 x | -33,58,265 x | - | - | - | - |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 95,651 | 2,02,988 | 2,56,237 | 2,66,455 | 3,20,552 | - | - |
| Reference price 2 | 0.2350 | 0.8500 | 0.3600 | 0.1950 | 0.0450 | 0.0450 | 0.0450 |
| Announcement Date | 29/12/20 | 09/12/21 | 29/11/22 | 29/11/23 | - | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.8812 | 1.514 | 6.494 | 23.18 | 21.91 | 27.68 | 39.51 |
| EBITDA | - | -15.4 | -27.47 | - | - | - | - |
| EBIT 1 | - | - | -28.45 | -29.52 | -15.32 | -6.267 | 0.43 |
| Operating Margin | - | - | -438.1% | -127.36% | -69.94% | -22.64% | 1.09% |
| Earnings before Tax (EBT) 1 | - | - | - | -30.26 | -16.47 | -6.267 | 0.43 |
| Net income 1 | - | - | - | -30.26 | -16.47 | -6.267 | 0.43 |
| Net margin | - | - | - | -130.53% | -75.2% | -22.64% | 1.09% |
| EPS 2 | -0.1500 | - | - | -0.1100 | -0.0500 | -0.0100 | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 29/12/20 | 09/12/21 | 29/11/22 | 29/11/23 | - | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: August | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.7896 | 0.7861 | 0.7411 | 4.177 | 5.668 | 5.355 | 6.027 | 6.131 | 5.946 | 5.031 | 5.465 | 5.464 | 6.09 | 6.643 | 7.197 |
| EBITDA | - | - | - | -9.01 | -6.288 | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | - | - | -9.638 | -6.703 | -7.093 | -6.526 | -8.624 | -4.165 | -5.045 | -3.644 | -2.469 | -1.742 | -1.547 | -1.532 |
| Operating Margin | - | - | - | -230.72% | -118.25% | -132.47% | -108.28% | -140.66% | -70.04% | -100.28% | -66.68% | -45.19% | -28.6% | -23.29% | -21.29% |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | -7.293 | -7.28 | -9.386 | -4.406 | -5.954 | -3.644 | -2.469 | -1.742 | -1.547 | -1.532 |
| Net income 1 | - | - | - | - | - | -7.331 | -7.289 | -9.338 | -4.406 | -5.954 | -3.644 | -2.469 | -1.742 | -1.547 | -1.532 |
| Net margin | - | - | - | - | - | -136.92% | -120.94% | -152.32% | -74.11% | -118.35% | -66.68% | -45.19% | -28.6% | -23.29% | -21.29% |
| EPS 2 | - | - | - | - | - | -0.0300 | -0.0300 | -0.0300 | -0.0200 | -0.0200 | -0.0100 | -0.0100 | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 20/01/22 | 14/04/22 | 14/07/22 | 29/11/22 | 16/01/23 | 13/04/23 | 17/07/23 | 29/11/23 | 15/01/24 | 13/04/24 | - | - | - | - | - |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | - | 1.25 | - | - | - | - |
| Capex / Sales | - | - | 19.19% | - | - | - | - |
| Announcement Date | 29/12/20 | 09/12/21 | 29/11/22 | 29/11/23 | - | - | - |
1CAD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.045
Average target price
-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -59.09% | 1.05Cr | |
| +19.41% | 4.55TCr | |
| +38.65% | 3.94TCr | |
| -8.62% | 3.85TCr | |
| +26.95% | 3.07TCr | |
| -13.50% | 2.6TCr | |
| +10.74% | 2.59TCr | |
| +44.87% | 1.41TCr | |
| +34.36% | 1.27TCr | |
| -7.14% | 1.13TCr |
- Stock Market
- Equities
- NUMI Stock
- Financials Numinus Wellness Inc.
